The anti-tumor activity of the PCBP2 siRNA nanocomplex and its combination with gemcitabine was evaluated in an orthotopic stroma-rich pancreatic cancer mouse model. This evidence concerns the gene PCBP2 and familial pancreatic carcinoma.